Vicarious Surgical (RBOTW) Net Cash Flow (2020 - 2025)
Vicarious Surgical (RBOTW) reported Net Cash Flow of -$746000.0 for Q3 2025, up 94.34% year-over-year from -$383862.7 in Q3 2024, and down 156.9% quarter-over-quarter from $1.3 million in Q2 2025.
Vicarious Surgical (RBOTW) Net Cash Flow (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Net Cash Flow data on file, last reported at -$746000.0 in Q3 2025.
- Net Cash Flow for Q3 2025 came in at -$746000.0, up 94.34% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.6 million (up 84.74% YoY), and the FY2024 annual result was -$43.1 million, up 32.03% from the prior year.
- Net Cash Flow declined to -$746000.0 in Q3 2025 per RBOTW's latest filing, from $1.3 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $177.3 million in Q3 2021 and troughed at -$62.1 million in Q1 2023.
- A 5-year average of -$678157.9 and a median of -$10.6 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 14969.13% in 2021 and fell as far as 1112.11% in 2021.
- A 5-year view of Net Cash Flow shows it stood at -$11.1 million in 2021, then rose by 4.66% to -$10.6 million in 2022, then surged by 40.59% to -$6.3 million in 2023, then jumped by 142.41% to $2.7 million in 2024, then sank by 127.96% to -$746000.0 in 2025.
- Business Quant data shows RBOTW's Net Cash Flow at -$746000.0 in Q3 2025, $1.3 million in Q2 2025, and -$7.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -746,000.00 |
| Sep 30, 2025 | -746,000.00 |
| Jun 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | -7.14 Mn |
| Mar 31, 2025 | -7.14 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | -13.18 Mn |
| Sep 30, 2024 | -13.18 Mn |
| Jun 30, 2024 | -17.97 Mn |
| Jun 30, 2024 | -17.97 Mn |
| Mar 31, 2024 | -14.60 Mn |
| Mar 31, 2024 | -14.60 Mn |
| Dec 31, 2023 | -6.29 Mn |
| Dec 31, 2023 | -6.29 Mn |
| Sep 30, 2023 | 26.31 Mn |
| Sep 30, 2023 | 26.31 Mn |
| Jun 30, 2023 | -21.28 Mn |
| Jun 30, 2023 | -21.28 Mn |